Alterations of biliary lipid composition in patients with fatty liver and those with cholesterol gallstone disease
脂肪肝和胆固醇胆石病患者胆汁脂质成分的变化
基本信息
- 批准号:06670519
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Formation of cholesterol supersaturated bile is a prerequisite for cholesterol gallstone disease. In order to elucidate mechanisms responsible for cholesterol supersaturated bile formation in patients with cholesterol gallstone disease, we focused on the motility of the gallbladder and small intestine, both of which are important in maintaining enterohepatic circulation of bile acids, in addition to the hepatic cholesterogenesis and bile acid synthesis. In gallstone patients with intact gallbladder emptying, the small intestinal transit and absorption of bile acids were not prolonged and impaired, as compared with control subjects. Therfore, the patients may not exhibit the characteristics of a decrease in circulating pool of bile acids, and accordingly their gallbladder bile does not become supersaturated with cholesterol. However, in patients with impaired gallbladder emptying, the small intestinal transit and absorption of bile acids were significantly prolonged and impaired. In such cases, the supersaturation of gallbladder bile may be due to the reduced pool of circulating bile acids brought about by changes in bile acid distribution, e.g., a sequestration into the hypomotile gallbladder and intestine. In gallstone patients, hepatic de novo cholesterol synthesis was significantly decreased as compared with control subjects. it is further suggested that in the formation of cholesterol supersaturated bile a hypersecretion of cholesterol derived from an exogeneous source may play a significant role.
胆固醇过饱和胆汁的形成是胆固醇结石病的先决条件。为了阐明胆固醇结石患者胆固醇过饱和胆汁形成的机制,我们重点研究了胆囊和小肠的运动,这两者除了肝脏胆固醇生成和胆汁酸合成外,在维持胆汁酸的肝肠循环方面也很重要。与对照组相比,胆囊排空完整的胆石症患者的小肠转运和胆汁酸吸收没有延长和受损。因此,患者可能不会表现出循环胆汁酸池减少的特征,因此他们的胆囊胆汁不会变得胆固醇过饱和。然而,在胆囊排空障碍的患者中,胆汁酸的小肠转运和吸收显著延长和受损。在这种情况下,胆囊胆汁的过饱和可能是由于胆汁酸分布的变化引起的循环胆汁酸池减少,例如,胆囊和小肠的隔离与对照组相比,胆结石患者的肝脏从头胆固醇合成显著减少。进一步表明,在胆固醇过饱和胆汁的形成中,源自外源的胆固醇分泌过多可能起重要作用。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Honda A, et al.: "Accumulation of 7α-hydroxycholesterol in liver tissue from cholesterol gallstone patients." Journal of Gastroenterology. (in press).
Honda A 等人:“胆固醇胆结石患者肝组织中 7α-羟基胆固醇的积累。”胃肠病学杂志(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Honda A, et al.: "Accumlation of 72-hydroxycholesterol in liver tissue from cholesterol gallstone patcents" Journal of Gastroenterology. 30. 651-656 (1995)
Honda A 等人:“胆固醇胆结石患者肝组织中 72-羟基胆固醇的累积”胃肠病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshida T, et al.: "Determination of 7α-hydroxy-4-cholesten-3-one level in human plasma using isotopedilution mass spectrometry and monitoring its circadian rhythm in human as an index" Journal of Chromatography Biomedical Application. 655. 179-187 (1994)
Yoshida T 等人:“使用同位素稀释质谱法测定人血浆中的 7α-羟基-4-胆固醇-3-酮水平并监测其昼夜节律作为指标”《色谱生物医学应用杂志》655。179-。 187 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shoda J,He B,Tanaka N,Matsuzaki Y.Osuga T,Yamamori S,Miyazaki H,Sjovall J: "Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone diseases and its correlation with de novo syntheses of cholesterol and bile acids in liver,
Shoda J,He B,Tanaka N,Matsuzaki Y.Osuga T,Yamamori S,Miyazaki H,Sjovall J:“胆固醇胆结石疾病患者过饱和胆汁中脱氧胆酸的增加及其与胆固醇和胆汁酸从头合成的相关性
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shoda J, et al.: "Plasma levels of mevalonate and 7d-hydroxy-4-cholesten-3-one in cholesterol gallstone disease and their etiological significance" Journal of Gastroenterology. 29. 94- (1994)
Shoda J 等人:“胆固醇胆结石疾病中甲羟戊酸和 7d-羟基-4-胆甾烯-3-酮的血浆水平及其病因学意义”《胃肠病学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHODA Junichi其他文献
SHODA Junichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHODA Junichi', 18)}}的其他基金
Improvement of metabolic and exercise function of skeletal muscles through activation of transcription factor, and prevention of obesity-related liver disease
通过转录因子的激活改善骨骼肌的代谢和运动功能,预防肥胖相关的肝病
- 批准号:
23300250 - 财政年份:2011
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inhibitory effects of exercise on progression of obesity-related liver diseases and development of glyco-biomarkers to scale the pathophysiology of the liver diseases
运动对肥胖相关肝病进展的抑制作用以及糖生物标志物的开发以衡量肝病的病理生理学
- 批准号:
22650162 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of novel cytotoxin therapy that targets tumor-associated surface molecules of biliary tract carcinoma
开发针对胆道癌肿瘤相关表面分子的新型细胞毒素疗法
- 批准号:
20390339 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of mucin glycoproteins in the gallbladder of BK5.erbB2 transgenic mouse
BK5.erbB2转基因小鼠胆囊粘蛋白糖蛋白分析
- 批准号:
15590618 - 财政年份:2003
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inflammation-Associated Lipid Mediators in Cholestatic Hepatobiliary Diseases and Effect of PAF-AH
胆汁淤积性肝胆疾病中炎症相关脂质介质及 PAF-AH 的作用
- 批准号:
12670456 - 财政年份:2000
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathogenetic Mechanism for Hypersecretion of Mucin Glycoprotein in Cholelithiasis
胆石症粘蛋白糖蛋白分泌过多的发病机制
- 批准号:
09670509 - 财政年份:1997
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
- 批准号:82370976
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
- 批准号:82371192
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
- 批准号:81302714
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Crosstalk between estrogen and bile acid signaling pathway
雌激素和胆汁酸信号通路之间的串扰
- 批准号:
8586795 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Crosstalk between estrogen and bile acid signaling pathway
雌激素和胆汁酸信号通路之间的串扰
- 批准号:
7865351 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Crosstalk between estrogen and bile acid signaling pathway
雌激素和胆汁酸信号通路之间的串扰
- 批准号:
8058734 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Tissue specific mechanism of FXR in suppressing bile-acid synthesis
FXR抑制胆汁酸合成的组织特异性机制
- 批准号:
8012056 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Crosstalk between estrogen and bile acid signaling pathway
雌激素和胆汁酸信号通路之间的串扰
- 批准号:
8442343 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Crosstalk between estrogen and bile acid signaling pathway
雌激素和胆汁酸信号通路之间的串扰
- 批准号:
8637064 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Crosstalk between estrogen and bile acid signaling pathway
雌激素和胆汁酸信号通路之间的串扰
- 批准号:
8240462 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Tissue specific mechanism of FXR in suppressing bile-acid synthesis
FXR抑制胆汁酸合成的组织特异性机制
- 批准号:
7867915 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
Tissue specific mechanism of FXR in suppressing bile-acid synthesis
FXR抑制胆汁酸合成的组织特异性机制
- 批准号:
8106415 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别:
Tissue specific mechanism of FXR in suppressing bile-acid synthesis
FXR抑制胆汁酸合成的组织特异性机制
- 批准号:
7633271 - 财政年份:2008
- 资助金额:
$ 1.28万 - 项目类别: